Univariate Analysis of VTE Frequency With and Without TA Administration

Abstract TKA and THA are associated with blood transfusion and risk for postoperative venothromboembolism (VTE). Reports show that tranexamic acid (TA) may be safe to use in high-risk orthopedic patients, but further data are needed to substantiate its use. All patients who underwent primary or revi...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of arthroplasty 2014, Vol.30 (2), p.272-276
Main Authors: Duncan, Christopher M., MD, Gillette, Blake P., MD, Jacob, Adam K., MD, Sierra, Rafael J., MD, Sanchez-Sotelo, Joaquin, MD, PhD, Smith, Hugh M., MD, PhD
Format: Article
Language:English
Subjects:
Orthopedics
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract TKA and THA are associated with blood transfusion and risk for postoperative venothromboembolism (VTE). Reports show that tranexamic acid (TA) may be safe to use in high-risk orthopedic patients, but further data are needed to substantiate its use. All patients who underwent primary or revision TKA or THA in a five year period were retrospectively identified. In 13,262 elective TKA or THA procedures, neither the odds of VTE (OR = 0.98; 95% CI 0.67-1.45; P = 0.939) or adjusted odds of death (OR = 0.26; 95% CI 0.04-1.80; P = 0.171) were significant with TA administration. The major findings of this large, single center, retrospective cohort study show the odds of postoperative VTE and 30-day mortality were unchanged with TA administration.
ISSN:0883-5403
DOI:10.1016/j.arth.2014.08.022